Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway

Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway

Tel: +47 21 07 81 60
E-mail:

Copyright/Disclaimer

List of DDDs for 3 years revision

The DDDs, which will be reviewed at the March 2025 meeting (3 year revision) are listed below. See also Guidelines: Part III; D Principles for reviewing and changing DDD and Part V; D Requests for changes to DDDs. The deadline for applications for alterations and comments is 1 February 2025.

ATC code	ATC level name (INN/generic name)	DDD	Unit	Adm.route

B02BX09	fostamatinib	0.2	g	O
B03XA05	roxadustat	43	mg	O
B06AC06	berotralstat	0.15	g	O
C01DX22	vericiguat	10	mg	O
C10AX15	bempedoic acid	0.18	g	O
C10AX16	inclisiran	1.6	mg	P
C10AX18	volanesorsen	20	mg	P
D11AH07	tralokinumab	16.1	mg	P
D11AH08	abrocitinib	0.15	g	O
G01AF21	tinidazole	0.2	g	V
J01GB06	amikacin	0.59	g	Inhal.solution
J05AB18	molnupiravir	1.6	g	O
J05AE30	nirmatrelvir and ritonavir	0.6 ¹⁾	g	O
J06BD05	sotrovimab	0.5	g	P
L04AC21	bimekizumab	5.7	mg	P
L04AE04 ²⁾	ponesimod	20	mg	O
L04AF04 ³⁾	filgotinib	0.2	g	O
L04AG12 ⁴⁾	ofatumumab	0.67	mg	P
L04AJ05 ⁵⁾	avacopan	60	mg	O
L04AX09	diroximel fumarate	0.924	g	O
M05BX05	burosumab	2.5	mg	P
M05BX06	romosozumab	7	mg	P
M09AX10	risdiplam	5	mg	O
N02CD06	rimegepant	37.5	mg	O
N03AX26	fenfluramine	8	mg	O
N07BC01	buprenorphine	1.6	mg	implant
N07XX15	inotersen	41	mg	P
P01CX04	miltefosine	0.15	g	O

1) refers to nirmatrelvir
2) ATC code L04AA50 altered Index 2024
3) ATC code L04AA45 altered Index 2024
4) ATC code L04AA52 altered Index 2024
5) ATC code L04AA59 altered Index 2024

Last updated: 2025-01-20